EDN1 and endothelial dysfunction: Outside of PAH, increased plasma levels of ET-1 are also associated with increased coronary [17] and systemic vasoconstriction [18] in coronary microvascular dysfunction, and endothelial dysfunction in vasospastic angina [19] highlighting that ET-1 dysregulation affects disparate vascular territories with adverse consequences.